Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Profit After Tax: 2020-2024

Historic Profit After Tax for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$14.7 million.

  • Journey Medical's Profit After Tax rose 3.14% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7 million, marking a year-over-year increase of 52.75%. This contributed to the annual value of -$14.7 million for FY2024, which is 280.79% down from last year.
  • Journey Medical's Profit After Tax amounted to -$14.7 million in FY2024, which was down 280.79% from -$3.9 million recorded in FY2023.
  • Journey Medical's 5-year Profit After Tax high stood at $5.3 million for FY2020, and its period low was -$44.0 million during FY2021.
  • For the 3-year period, Journey Medical's Profit After Tax averaged around -$16.1 million, with its median value being -$14.7 million (2024).
  • In the last 5 years, Journey Medical's Profit After Tax crashed by 932.75% in 2021 and then skyrocketed by 87.00% in 2023.
  • Journey Medical's Profit After Tax (Yearly) stood at $5.3 million in 2020, then crashed by 932.75% to -$44.0 million in 2021, then surged by 32.65% to -$29.6 million in 2022, then soared by 87.00% to -$3.9 million in 2023, then plummeted by 280.79% to -$14.7 million in 2024.